SCSC
SCANSOURCE, INC.
$48.15
+3.08%
$993.3M
No data for this timeframe.
Vol
Market Cap$993.3M
Cap SizeSmall Cap
Inst. Holders6 funds
Inst. Value$147.4M
Inst. Activity2 buys / 0 sells
Insider Activity1B / 2S
Insider Net $-$715.4K
SEC Reports1
Exchange Nasdaq·Sector Wholesale-Computers & Peripheral Equipment & Software·CIK 0000918965·Prev Close $46.71
Recent Activity
Jun 5, 2026
SEC
ScanSource eliminated the role of Senior EVP and CIO Rachel Hayden, effective June 8, 2026. The departure is a role elim
8-K — Impact 2/10
Jun 1, 2026
Insider
Smith Shana C sold 1,025 shares
Sr. EVP & Chief Legal Officer @ $48.13 ($49.3K)
May 7, 2026
earnings_calendar
SCSC Q3 2026 Earnings Scheduled — 2026-05-07
Mar 16, 2026
Insider
BAUR MICHAEL L sold 3,827 shares
CEO, President, BOD Chair @ $35.89 ($137.4K)
Mar 13, 2026
Insider
BAUR MICHAEL L sold 21,104 shares
CEO, President, BOD Chair @ $35.76 ($754.7K)
Inst.
FMR LLC — ADD
55,453 shares ($2.2M)
Inst.
WELLS FARGO & COMPANY/MN — ADD
29,683 shares ($1.2M)
Price Targets
Historical data — last covering-analyst action Oct 2025. No current recommendation available.
$54.67 (Oct 2025)
Current $48.87
Low $43.00
Median $50.00
High $71.00
3 analysts
$43.00
$71.00
Analyst Ratings
3Strong Buy
3Buy
3Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 8, 2025 | Barclays | INITIATE | Equal-Weight |
| Aug 15, 2024 | Raymond James | DOWNGRADE | Outperform → Market Perform |
| Dec 19, 2023 | Northcoast Research | DOWNGRADE | Buy → Neutral |
| Nov 10, 2023 | Raymond James | MAINTAIN | Outperform → Outperform |
| Aug 23, 2023 | Northcoast Research | UPGRADE | Neutral → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.14 ▼ -2.2% | $1.04 — $1.19 | 12% YoY | 4 |
| Next Q | $1.04 | $0.88 — $1.18 | -2% YoY | 4 |
| Current FY | $3.94 ▼ -1.2% | $3.83 — $3.98 | 10% YoY | 4 |
| Next FY | $4.41 ▼ -1.1% | $4.21 — $4.60 | 12% YoY | 4 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $110.4M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $21.0M | NEW |
| MORGAN STANLEY | $9.9M | TRIM |
| BANK OF AMERICA CORP | $2.8M | — |
| FMR LLC | $2.2M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Smith Shana | F | $49.3K |
| Mar 16, 2026 | BAUR MICHAEL | SELL | $137.4K |
| Mar 13, 2026 | BAUR MICHAEL | SELL | $754.7K |
| Feb 11, 2026 | Mathis Charles | BUY | $176.6K |
6 institutional holders with $147.4M total value (3,773,841 shares) as of 2025-Q4. Top holders: VANGUARD, CHARLES, MORGAN. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 2,827,007 | $110.4M | 74.9% | — |
| 2 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 538,021 | $21.0M | 14.3% | NEW |
| 3 | MORGAN STANLEY | 252,831 | $9.9M | 6.7% | TRIM -26.3% |
| 4 | BANK OF AMERICA CORP /DE/ | 70,846 | $2.8M | 1.9% | — |
| 5 | FMR LLC | 55,453 | $2.2M | 1.5% | ADD +35.6% |
| 6 | WELLS FARGO & COMPANY/MN | 29,683 | $1.2M | 0.8% | ADD +39.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | ADD | 40,901 | 55,453 | +35.6% | $2.2M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 21,226 | 29,683 | +39.8% | $1.2M | 2025-Q4 |
| UBS Group AG | DOUBLED | 29,915 | 76,332 | +155.2% | $3.4M | 2025-Q3 |
| FMR LLC | DOUBLED | 2,504 | 40,901 | +1533.4% | $1.8M | 2025-Q3 |
| NORGES BANK | EXIT | 16,300 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 16,300 | — | $681.5K | 2025-Q2 |
| FMR LLC | ADD | 1,846 | 2,504 | +35.6% | $104.7K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 6,035 | 0 | -100.0% | $0.00 | 2025-Q2 |
| CITADEL ADVISORS LLC | DOUBLED | 144,800 | 375,632 | +159.4% | $12.8M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 6,035 | — | $205.3K | 2025-Q1 |
| NORGES BANK | EXIT | 87,184 | 0 | -100.0% | $0.00 | 2025-Q1 |
| MORGAN STANLEY | TRIM | 390,088 | 287,565 | -26.3% | $13.6M | 2024-Q4 |
| CITADEL ADVISORS LLC | ADD | 106,231 | 144,800 | +36.3% | $6.9M | 2024-Q4 |
| UBS Group AG | ADD | 16,281 | 32,383 | +98.9% | $1.5M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 424,434 | — | $20.4M | 2024-Q3 |
| MORGAN STANLEY | ADD | 253,895 | 390,088 | +53.6% | $18.7M | 2024-Q3 |
3 unique insiders with 3 transactions. Net insider value: -$715.4K ($176.6K bought, $892.0K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Smith Shana C | Sr. EVP & Chief Legal Officer | F | 1,025 | $48.13 | $49.3K |
| Mar 16, 2026 | BAUR MICHAEL L | CEO, President, BOD Chair | SELL | 3,827 | $35.89 | $137.4K |
| Mar 13, 2026 | BAUR MICHAEL L | CEO, President, BOD Chair | SELL | 21,104 | $35.76 | $754.7K |
| Feb 11, 2026 | Mathis Charles Alexander | Director | BUY | 5,000 | $35.32 | $176.6K |
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 2.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Oct 2025): 67% buy across 9 analysts — 3 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Oct 2025. No current recommendation available.
$54.67 mean target (Oct 2025)
$43.00 Low
$71.00 High
| Metric | Value |
|---|---|
| Current Price | $48.87 |
| Target Low | $43.00 |
| Target Mean | $54.67 |
| Target Median | $50.00 |
| Target High | $71.00 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.14 | $1.04 | $1.19 | 11.8% | -2.2% | 1↑ 3↓ | $0.8B | -1.3% | 4 |
| Next Q 2026-09-30 |
$1.04 | $0.88 | $1.18 | -2.1% | -0.2% | 2↑ 2↓ | $0.8B | 3.3% | 4 |
| Current FY 2026-06-30 |
$3.94 | $3.83 | $3.98 | 10.4% | -1.2% | 1↑ 3↓ | $3.1B | 1.1% | 4 |
| Next FY 2027-06-30 |
$4.41 | $4.21 | $4.60 | 11.9% | -1.1% | 1↑ 3↓ | $3.2B | 4.0% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.141 | |
| 7d ago | $1.134 | +0.007 |
| 30d ago | $1.167 | -0.026 |
| 60d ago | $1.167 | -0.026 |
| 90d ago | $1.180 | -0.039 |
5 analyst firms have rated this stock: 4 upgrades, 4 downgrades, 2 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Oct 8, 2025 | Barclays | INITIATE | — | Equal-Weight |
| Aug 15, 2024 | Raymond James | DOWNGRADE | Outperform | Market Perform |
| Dec 19, 2023 | Northcoast Research | DOWNGRADE | Buy | Neutral |
| Nov 10, 2023 | Raymond James | MAINTAIN | Outperform | Outperform |
| Aug 23, 2023 | Northcoast Research | UPGRADE | Neutral | Buy |
| Nov 9, 2022 | Raymond James | MAINTAIN | — | Outperform |
| Nov 10, 2021 | Raymond James | MAINTAIN | — | Outperform |
| Aug 25, 2021 | Raymond James | MAINTAIN | — | Outperform |
| Jul 28, 2021 | Northcoast Research | UPGRADE | Neutral | Buy |
| May 11, 2021 | Raymond James | MAINTAIN | — | Outperform |
| Feb 3, 2021 | Raymond James | MAINTAIN | — | Outperform |
| Nov 10, 2020 | Raymond James | MAINTAIN | — | Outperform |
| May 12, 2020 | Raymond James | MAINTAIN | — | Outperform |
| Nov 13, 2019 | Raymond James | MAINTAIN | — | Outperform |
| Aug 21, 2019 | Raymond James | MAINTAIN | — | Outperform |
| Aug 29, 2018 | Raymond James | MAINTAIN | Outperform | Outperform |
| Mar 26, 2018 | Northcoast Research | UPGRADE | Neutral | Buy |
| Aug 30, 2016 | Raymond James | MAINTAIN | — | Outperform |
| Nov 11, 2014 | Wells Fargo | INITIATE | — | Market Perform |
| Jan 3, 2014 | Northcoast Research | DOWNGRADE | Buy | Neutral |
| Jun 7, 2013 | Northcoast Research | UPGRADE | Neutral | Buy |
| Aug 14, 2012 | Keybanc | DOWNGRADE | Buy | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| May 1, 2026 | 1 | 0 | 3 | 2 | 2 | 13% | |
| Apr 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| Mar 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| Feb 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| Jan 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 7, 2026
earnings_calendar
SCSC Q3 2026 Earnings Scheduled — 2026-05-07